Elevation Oncology Inc (ELEV)
Elevation Oncology Market Cap: 197.24M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 17, 2024 | 197.24M |
May 16, 2024 | 197.24M |
May 15, 2024 | 203.80M |
May 14, 2024 | 194.51M |
May 13, 2024 | 193.42M |
May 10, 2024 | 179.21M |
May 09, 2024 | 191.78M |
May 08, 2024 | 195.61M |
May 07, 2024 | 190.14M |
May 06, 2024 | 204.35M |
May 03, 2024 | 202.16M |
May 02, 2024 | 208.72M |
May 01, 2024 | 218.55M |
April 30, 2024 | 193.97M |
April 29, 2024 | 210.36M |
April 26, 2024 | 197.79M |
April 25, 2024 | 199.16M |
April 24, 2024 | 212.00M |
April 23, 2024 | 236.04M |
April 22, 2024 | 221.29M |
April 19, 2024 | 207.63M |
April 18, 2024 | 219.10M |
April 17, 2024 | 226.20M |
April 16, 2024 | 239.86M |
April 15, 2024 | 242.05M |
Date | Value |
---|---|
April 12, 2024 | 244.44M |
April 11, 2024 | 255.30M |
April 10, 2024 | 237.73M |
April 09, 2024 | 243.41M |
April 08, 2024 | 239.79M |
April 05, 2024 | 253.75M |
April 04, 2024 | 261.50M |
April 03, 2024 | 267.18M |
April 02, 2024 | 265.12M |
April 01, 2024 | 257.88M |
March 28, 2024 | 249.58M |
March 27, 2024 | 243.74M |
March 26, 2024 | 243.26M |
March 25, 2024 | 222.82M |
March 22, 2024 | 218.93M |
March 21, 2024 | 219.42M |
March 20, 2024 | 211.15M |
March 19, 2024 | 214.06M |
March 18, 2024 | 212.12M |
March 15, 2024 | 213.58M |
March 14, 2024 | 192.66M |
March 13, 2024 | 202.88M |
March 12, 2024 | 198.50M |
March 11, 2024 | 213.58M |
March 08, 2024 | 222.34M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
Merrimack Pharmaceuticals Inc | 223.75M |
TG Therapeutics Inc | 2.547B |
Mersana Therapeutics Inc | 334.05M |
Equillium Inc | 55.00M |
Monopar Therapeutics Inc | 10.67M |
Market Cap Related Metrics
Price to Book Value | 2.602 |
Price | 3.60 |
Earnings Yield | -27.15% |